RPG Stock Overview
An investment holding company, holds investments in the healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Regent Pacific Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.039 |
| 52 Week High | HK$0.09 |
| 52 Week Low | HK$0.02 |
| Beta | 1.04 |
| 11 Month Change | -7.14% |
| 3 Month Change | -28.44% |
| 1 Year Change | -48.68% |
| 33 Year Change | -84.40% |
| 5 Year Change | -75.63% |
| Change since IPO | -95.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| RPG | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -10.3% | 1.6% | 1.1% |
| 1Y | -48.7% | -19.0% | 7.2% |
Return vs Industry: RPG underperformed the German Pharmaceuticals industry which returned -18.3% over the past year.
Return vs Market: RPG underperformed the German Market which returned 8.6% over the past year.
Price Volatility
| RPG volatility | |
|---|---|
| RPG Average Weekly Movement | 15.3% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: RPG's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: RPG's weekly volatility has decreased from 30% to 15% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 17 | Jamie Alexander Gibson | www.regentpac.com |
Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels.
Regent Pacific Group Limited Fundamentals Summary
| RPG fundamental statistics | |
|---|---|
| Market cap | €10.98m |
| Earnings (TTM) | -€14.64m |
| Revenue (TTM) | €48.27k |
227.4x
P/S Ratio-0.7x
P/E RatioIs RPG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RPG income statement (TTM) | |
|---|---|
| Revenue | US$51.00k |
| Cost of Revenue | US$1.22m |
| Gross Profit | -US$1.17m |
| Other Expenses | US$14.30m |
| Earnings | -US$15.47m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.068 |
| Gross Margin | -2,288.24% |
| Net Profit Margin | -30,335.29% |
| Debt/Equity Ratio | -18.0% |
How did RPG perform over the long term?
See historical performance and comparison